Total Liabilities: The total value of all possible claims against the corporation.
CRISPR Therapeutics AG (CRSP) had Total Liabilities of $343.43M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.51M |
|
$-581.60M |
|
-- |
|
$3.51M |
|
$668.08M |
|
$-664.57M |
|
$86.61M |
|
$-577.97M |
|
$-577.97M |
|
$-581.60M |
|
$-581.60M |
|
$-581.60M |
|
$-581.60M |
|
$-664.57M |
|
$-645.09M |
|
89.92M |
|
89.92M |
|
$-6.47 |
|
$-6.47 |
|
| Balance Sheet Financials | |
$1.99B |
|
$115.85M |
|
$279.57M |
|
$2.27B |
|
$149.12M |
|
-- |
|
$194.31M |
|
|
Total Liabilities |
$343.43M |
$1.92B |
|
$1.92B |
|
$1.92B |
|
95.89M |
|
| Cash Flow Statement Financials | |
$-345.01M |
|
$-31.80M |
|
$426.03M |
|
$309.78M |
|
$359.08M |
|
$49.30M |
|
$72.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-18933.65% |
|
-18933.65% |
|
-18378.69% |
|
-16466.24% |
|
-16569.77% |
|
$-345.93M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-30.26% |
|
-30.26% |
|
-25.67% |
|
-30.26% |
|
$20.04 |
|
$-3.85 |
|
$-3.84 |
|